8-K
PROCTER & GAMBLE Co (PG)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 20, 2022
THE PROCTER & GAMBLE COMPANY
(Exact Name of Registrant as Specified in Charter)
| Ohio | 001-00434 | 31-0411980 |
|---|---|---|
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
One Procter & Gamble Plaza, Cincinnati, Ohio 45202
(Address of Principal Executive Offices, and Zip Code)
513-983-1100
Registrant’s Telephone Number, Including Area Code
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| --- | --- |
| ☐ | Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| --- | --- |
| ☐ | Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| --- | --- |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common Stock without Par Value | PG | New York Stock Exchange |
| 2.000% Notes due 2022 | PG22B | New York Stock Exchange |
| --- | --- | --- |
| 1.125% Notes due 2023 | PG23A | New York Stock Exchange |
| 0.500% Notes due 2024 | PG24A | New York Stock Exchange |
| 0.625% Notes due 2024 | PG24B | New York Stock Exchange |
| 1.375% Notes due 2025 | PG25 | New York Stock Exchange |
| 0.110% Notes due 2026 | PG26D | New York Stock Exchange |
| 4.875% EUR notes due May 2027 | PG27A | New York Stock Exchange |
| 1.200% Notes due 2028 | PG28 | New York Stock Exchange |
| 1.250% Notes due 2029 | PG29B | New York Stock Exchange |
| 1.800% Notes due 2029 | PG29A | New York Stock Exchange |
| 6.250% GBP notes due January 2030 | PG30 | New York Stock Exchange |
| 0.350% notes due 2030 | PG30C | New York Stock Exchange |
| 0.230% notes due 2031 | PG31A | New York Stock Exchange |
| 5.250% GBP Notes due January 2033 | PG33 | New York Stock Exchange |
| 1.875% Notes due 2038 | PG38 | New York Stock Exchange |
| 0.900% Notes due 2041 | PG41 | New York Stock Exchange |
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934<br> (§240.12b-2 of this chapter). | ||
| --- | --- | --- |
| Emerging growth company | ☐ | |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting<br> standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
ITEM 7.01 REGULATION FD DISCLOSURE
On April 20, 2022, The Procter & Gamble Company (the "Company") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website.
This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure."
| ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS |
|---|
(d) Exhibits
| Exhibit Number | Description |
|---|---|
| 99.1 | Informational Slides Provided by The Procter & Gamble Company dated April 20, 2022. |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| SIGNATURE<br><br> <br><br><br> <br>Pursuant to the requirements of the Securities Exchange Act of 1934, the<br> Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. | |
| --- |
THE PROCTER & GAMBLE COMPANY
BY: /s/ Sandra T. Lane
Sandra T. Lane
Assistant Secretary
April 20, 2022
INDEX TO EXHIBIT(S)
| Exhibit Number | Description |
|---|---|
| 99.1 | Informational Slides Provided by The Procter & Gamble Company dated April 20, 2022. |
Earnings Release Q3 FY 2022ResultsApril 20, 2022
SUPERIORITYTO WIN WITH CONSUMERS LEADING CONSTRUCTIVE DISRUPTION FOCUSED & AGILE ORGANIZATION STRATEGIC FOCUS AREAS PORTFOLIO: DAILY USE, PERFORMANCE DRIVES BRAND CHOICE PRODUCTIVITY TO FUEL INVESTMENTS Products Packaging Value New Standard Of Excellence Communication Retail Execution
Business ResultsQ3 FY 2022
Q3 FY 2022 HIGHLIGHTS
Organic Sales Growth Organic Volume Growth Core EPS Growth Free CashFlow Productivity Q3 FY ‘22 +10% +3% +6% 74% Currency Neutral Core EPS Growth +10% Q3 FY 2022 RESULTS
Pricing contributed 5 points, volume contributed 3 points and mix added 2 point to sales growth. ORGANIC SALES GROWTHQ3 FY 2022 RESULTS
Core gross margin -400 basis points Core operating margin -10 basis points Total productivity savings +170 basis points CORE EPS GROWTHQ3 FY 2022 RESULTS
Core gross margin ex-FX -380 basis points Core operating margin ex-FX +20 basis points CURRENCY NEUTRAL CORE EPS GROWTHQ3 FY 2022 RESULTS
GLOBAL MARKET SHARES Top 50 Category/ Country Combinations # Grew/Held Value Share
Business Segment Results and HighlightsQ3 FY 2022
Topline: +4% Pricing, flat Mix, -1% Volume Global Skin & Personal Care value share increased 0.6 points and Global Hair Care value share decreased 1.1 points versus year ago. Net Earnings: Driven by pricing partially offset by commodities, foreign exchange and brand mix. Q3 FY 2022 RESULTSBEAUTY SEGMENT
Beauty Segment has delivered 26 consecutive quarters of organic sales growth through Q3. Hair Care organic sales increased low single digits versus year ago. North America grew low single digits driven by pricing. Europe grew double digits behind premiumization and pricing. Growth in Latin America and Japan driven by pricing. This was partially offset by a low single digit decline in Greater China. Skin & Personal Care organic sales increased low single digits versus year ago. Double digit growth in North America and Europe and over 30% growth in Latin America was offset by a double digit decline in Greater China. This was driven by COVID lockdowns during the quarter. On a global basis, Antiperspirants / Deodorants grew over 20%, Personal Cleansing grew high single digits and Skin Care declined mid-single digits driven by SK-II. Q3 FY 2022 RESULTSBEAUTY HIGHLIGHTS
Q3 FY 2022 RESULTSGROOMING SEGMENT Topline: +6% Pricing, +1% Volume, +1% Mix Global Grooming value share increased 1.1 points versus year ago. Both Global Shave share and Global Appliances share increased versus year ago. Net Earnings: Pricing and volume were partially offset by foreign exchange.
Shave Care organic sales grew double digits, with growth in every region. Growth was driven by volume, premium innovation and pricing. Appliances organic sales declined low single digits. North America grew more than 30% driven by volume, premium innovation and pricing. Europe declined double digits, driven by a COVID-surge in the base period. On a 2-year stack basis, Europe Appliances grew over 20%. Q3 FY 2022 RESULTSGROOMING HIGHLIGHTS
Topline: +8% Volume, +5% Mix, +3% Pricing Global value share increased 0.4 points in Oral Care and 0.2 points in Personal Health Care versus year ago. Net Earnings: Volume, positive mix and pricing were partially offset by foreign exchange, freight and commodities. Q3 FY 2022 RESULTSHEALTH CARE SEGMENT
Oral Care organic sales increased high single digits versus year ago behind premiumization across forms, volume and pricing. North America grew high single digits, with growth in all forms (toothbrush, paste, denture, rinse, floss and whitening). Personal Health Care organic sales grew over 30% versus year ago, benefitting partially from a low cough cold flu season base. Growth was broad based, with North America growing nearly 50% and Europe growing mid-teens. Globally, growth is driven by volume and positive mix behind the respiratory business and double-digit growth in digestive wellness and sleep. Q3 FY 2022 RESULTSHEALTH CARE HIGHLIGHTS
Topline: +5% Volume, +5% Pricing Global value share increased 1.8 points versus year ago, with a 1.5 points of share growth in Fabric Care and nearly 2 points in Home Care. Net Earnings: Pricing and volume were more than offset by significant commodity and freight costs. Q3 FY 2022 RESULTSFABRIC & HOME SEGMENT
Fabric Care organic sales grew double digits versus year ago. Growth is balanced across product forms. Growth continues to be driven by premium innovation, with global Laundry Unit-Dose growing mid-teens and Fabric Enhancer Beads growing more than 20%. Home Care organic sales increased mid-single digits, with growth across all subcategories – Dish Care, Air Care and Surface Care. Premium innovation and continued share increases enabled growth on top of a significant COVID related consumption surge in the base period. Two-year stacked, Home Care grew more than 20%. Q3 FY 2022 RESULTSFABRIC & HOME HIGHLIGHTS
Topline: +5% Pricing, +3% Mix, +2% Volume Global value share for the Baby, Feminine and Family Care segment increased 1 point versus year ago, with share growth in all 3 categories. Net Earnings: Pricing and volume were more than offset by significant commodity and freight costs. Q3 FY 2022 RESULTSBABY, FEMININE and FAMILY CARE SEGMENT
Baby Care organic sales increased double digits. North America and Europe grew high-teens behind pricing and mix driven by premium innovation. This was partially offset by a decline in Greater China, driven by strong competitive activity. Feminine Care organic sales grew double digits, with growth in all regions. Base Feminine Care grew double digits and Adult Incontinence grew over 20%, driven by premiumization and pricing. Family Care organic sales grew mid-single digits, driven by volume and pricing. Organic sales grew in all sub-categories: Paper Towels, Toilet Tissue and Facial Tissue. Q3 FY 2022 RESULTSBABY, FEMININE and FAMILY CARE HIGHLIGHTS
FY 2022 Guidance
FY ‘22 Organic Sales Growth +6% to +7% All-in Sales Growth +4% to +5% FY 2022 GuidanceSALES Increased organic sales growth +6% to +7% Increased all-in sales growth +4% to +5% Includes a two percent negative impact from foreign exchange
FY ‘22 FY ’21 Base Period EPS Core EPS Growth +3% to +6% $5.66 All-in EPS Growth +6% to +9% $5.50 FY 2022 GuidanceEARNINGS PER SHARE Maintained Core EPS growth +3% to +6% $3.2bn after tax commodity, freight & foreign exchange headwinds represent a $1.26 per share impact to FY ’22 Core EPS (22% headwind on Core EPS growth) Maintained All-in EPS growth +6% to +9% Core effective tax rate 18% to 19%
FY 2022 GuidanceCASH GENERATION AND USAGE Maintained Free Cash Flow Productivity: 95% Capital Spending, % Sales: 4% to 5% Dividends: >$8B Increased Direct Share Repurchase: ~$10B
Significant deceleration of market growth rates Significant currency weakness Significant further commodity and freight cost increases Major supply chain disruption or store closures Additional geo-political disruptions and economic volatility FY 2022 GuidancePOTENTIAL HEADWINDS NOT INCLUDED IN GUIDANCE
The Procter & Gamble Company Regulation G Reconciliation of Non-GAAP Measures
In accordance with the SEC's Regulation G, the following provides definitions of the non-GAAP measures used in Procter & Gamble's April 20, 2022 earnings call, associated slides, and other materials and the reconciliation to the most closely related GAAP measure. Management believes that these non-GAAP measures provide useful perspective on underlying business trends and provide a supplemental measure of period-to-period financial results. Disclosing these non-GAAP financial measures allows investors and management to view our operating results excluding the impact of items that are not reflective of the underlying operating performance. Management uses these non-GAAP measures in making operating decisions, allocating financial resources and for business strategy purposes. Certain of these measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, the company’s reported results prepared in accordance with GAAP. Our non-GAAP financial measures do not represent a comprehensive basis of accounting. Therefore, our non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies. The Company is not able to reconcile its forward-looking non-GAAP cash flow and tax rate measures because the Company cannot predict the timing and amounts of discrete items such as acquisition and divestitures, which could significantly impact GAAP results.
The measures provided are as follows:
| 1. | Organic sales growth — page 3 |
|---|---|
| 2. | Core EPS and currency-neutral Core EPS — page 4 |
| --- | --- |
| 3. | Core gross margin and currency-neutral Core gross margin – page 6 |
| --- | --- |
| 4. | Core operating profit margin and currency-neutral Core operating profit margin — page 6 |
| --- | --- |
| 5. | Adjusted free cash flow productivity — page 7 |
| --- | --- |
The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:
| ◾ | Incremental restructuring: The Company has historically had an ongoing level of restructuring activities. Such activities have resulted in<br> ongoing annual restructuring related charges of approximately $250 - $500 million before tax. Beginning in 2012, the Company had a strategic productivity and cost savings initiative that resulted in incremental restructuring charges. The<br> adjustment to Core earnings includes only the restructuring costs above what we believe are the normal recurring level of restructuring costs. In fiscal 2021 and onwards, the Company incurred restructuring costs within our historical<br> ongoing level. |
|---|---|
| ◾ | Early debt extinguishment charges: In the three months ended December 31, 2020, the company recorded after tax charges of $427 million<br> ($512 million before tax), due to early extinguishment of certain long-term debt. These charges represent the difference between the reacquisition price and the par value of the debt extinguished. |
| --- | --- |
We do not view the above items to be part of our sustainable results, and their exclusion from core earnings measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation.
Organic sales growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures, the impact from the July 1, 2018 adoption of new accounting standards for “Revenue from Contracts with Customers”, the impact from India Goods and Services Tax changes (which were effective on July 1, 2017), the impact of Venezuela deconsolidation in 2016 and foreign exchange from year-over-year comparisons. Management believes this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is used in assessing achievement of management goals for at-risk compensation.
Core EPS and currency-neutral Core EPS*: Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share from continuing operations adjusted as indicated. Currency-neutral Core EPS is a measure of the Company's Core EPS excluding the incremental current year impact of foreign exchange.
Core gross margin: Core gross margin is a measure of the Company's gross margin adjusted for items as indicated. For the three months ended March 31, 2022 compared with the three months ended March 31, 2021, there are no adjustments to or reconciling items for gross margin.
Currency-neutral Core gross margin: Currency-neutral Core gross margin is a measure of the Company's Core gross margin excluding the incremental current year impact of foreign exchange.
Core operating profit margin*: Core
operating profit margin is a measure of the Company's operating margin adjusted for items as indicated. For the three months ended March 31, 2022 compared with the three months ended March 31, 2021, there are no adjustments to or reconciling items
for operating profit margin.
Currency-neutral Core operating profit margin*: Currency-neutral Core operating profit margin is a measure of the Company's Core operating profit margin excluding the incremental current year impact of foreign exchange.
Free cash flow: Free cash flow is defined as operating cash flow less capital spending. Free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. Management views free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investment.
Free cash flow productivity*: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. Management views free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. This measure is used by management in making operating decisions, allocating financial resources and for budget planning purposes. The Company's long-term target is to generate annual free cash flow productivity at or above 90 percent.
* Measure is used to evaluate senior management and is a factor in determining their at-risk compensation.
- Organic sales growth:
| Three Months Ended<br><br> March 31, 2022 | Net Sales Growth | Foreign Exchange Impact | Acquisition &<br><br> Divestiture Impact/Other* | Organic Sales Growth |
|---|---|---|---|---|
| Beauty | 2% | 2% | (1)% | 3% |
| Grooming | 3% | 5% | -% | 8% |
| Health Care | 13% | 3% | -% | 16% |
| Fabric Care & Home Care | 7% | 3% | -% | 10% |
| Baby, Feminine & Family Care | 7% | 3% | -% | 10% |
| Total P&G | 7% | 3% | -% | 10% |
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Organic Sales
Fiscal Year to Date
| Nine Months Ended<br><br> <br>March 31, 2022 | Net Sales Growth | Foreign Exchange Impact | Acquisition/ Divestiture Impact/Other* | Organic Sales Growth |
|---|---|---|---|---|
| Total P&G | 6% | 1% | -% | 7% |
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Organic Sales
Prior Quarters
| Total Company | Net Sales Growth | Foreign Exchange Impact | Acquisition/ Divestiture Impact/Other* | Organic Sales Growth |
|---|---|---|---|---|
| JAS 2020 | 9% | 1% | (1)% | 9% |
| OND 2020 | 8% | -% | -% | 8% |
| JFM 2021 | 5% | (1)% | -% | 4% |
| AMJ 2021 | 7% | (3)% | -% | 4% |
| JAS 2021 | 5% | (1)% | -% | 4% |
| OND 2021 | 6% | -% | -% | 6% |
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Organic Sales
Prior Quarters Beauty
| Total Beauty | Net Sales Growth | Foreign Exchange Impact | Acquisition/ Divestiture Impact/Other* | Organic Sales Growth |
|---|---|---|---|---|
| OND 2015 | (10)% | 7% | 4% | 1% |
| JFM 2016 | (8)% | 5% | 4% | 1% |
| AMJ 2016 | (5)% | 3% | 3% | 1% |
| JAS 2016 | (1)% | 2% | 2% | 3% |
| OND 2016 | (1)% | 2% | 2% | 3% |
| JFM 2017 | (2)% | 1% | 2% | 1% |
| AMJ 2017 | 2% | 2% | 1% | 5% |
| JAS 2017 | 5% | -% | -% | 5% |
| OND 2017 | 10% | (1)% | -% | 9% |
| JFM 2018 | 10% | (5)% | -% | 5% |
| AMJ 2018 | 10% | (3)% | -% | 7% |
| JAS 2018 | 5% | 3% | (1)% | 7% |
| OND 2018 | 4% | 4% | -% | 8% |
| JFM 2019 | 4% | 5% | -% | 9% |
| AMJ 2019 | 3% | 5% | -% | 8% |
| JAS 2019 | 8% | 2% | -% | 10% |
| OND 2019 | 7% | 1% | -% | 8% |
| JFM 2020 | (1)% | 2% | -% | 1% |
| AMJ 2020 | -% | 4% | (1)% | 3% |
| JAS 2020 | 7% | 1% | (1)% | 7% |
| OND 2020 | 6% | (1)% | -% | 5% |
| JFM 2021 | 9% | (2)% | -% | 7% |
| AMJ 2021 | 11% | (5)% | -% | 6% |
| JAS 2021 | 5% | (3)% | -% | 2% |
| OND 2021 | 3% | (1)% | -% | 2% |
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures for all periods, the impact from the July 1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers", the impact of India Goods and Services Tax implementation in FY 2018, the impact of Venezuela deconsolidation in 2016 and rounding impacts necessary to reconcile net sales to organic sales.
Organic Sales
Guidance
| Total Company | Net Sales Growth | Combined Foreign Exchange &<br><br> <br>Acquisition/Divestiture Impact/Other* | Organic Sales Growth |
|---|---|---|---|
| FY 2022 (Estimate) | +4% to +5% | +2% | +6% to +7% |
* Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
- Core EPS and currency-neutral Core EPS:
| Three Months Ended<br> March 31 | |
|---|---|
| 2022 | |
| Diluted Net EPS | 1.33 |
| Percentage change vs. prior period | 6% |
| Adjustments | - |
| Core EPS | 1.33 |
| Percentage change vs. prior period Core EPS | 6% |
| Currency Impact to Earnings | 0.05 |
| Currency-Neutral Core EPS | 1.38 |
| Percentage change vs. prior period Core EPS | 10% |
All values are in US Dollars.
*For the three months ended March 31, 2022 compared with the three months ended March 31, 2021, there are no adjustments to or reconciling items for diluted net earnings per share.
Core EPS
Prior Quarters
| JAS 20 | OND 20 | JFM 21 | AMJ 21 | JAS 21 | OND 21 | |
|---|---|---|---|---|---|---|
| Diluted Net Earnings Per Share attributable to P&G | 1.63 | 1.47 | 1.26 | 1.13 | 1.61 | 1.66 |
| Incremental Restructuring | - | - | - | - | - | - |
| Early Debt Extinguishment | - | 0.16 | - | - | - | - |
| Rounding | - | 0.01 | - | - | - | - |
| Core EPS | 1.63 | 1.64 | 1.26 | 1.13 | 1.61 | 1.66 |
| Percentage change vs. prior period | 19% | 15% | 8% | (3)% | (1)% | 1% |
| Currency Impact to Earnings | 0.04 | 0.03 | - | (0.02) | (0.03) | (0.02) |
| Currency-Neutral Core EPS | 1.67 | 1.67 | 1.26 | 1.11 | 1.58 | 1.68 |
| Percentage change vs. prior period Core EPS | 22% | 18% | 8% | (4)% | (3)% | 2% |
All values are in US Dollars.
Note – All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction
Core EPS
Guidance
| Total Company | Diluted EPS Growth | Impact of Incremental<br><br> <br>Non-Core Items* | Core EPS Growth |
|---|---|---|---|
| FY 2022 (Estimate) | +6% to +9% | (3)% | +3% to +6% |
* Includes impact of charges for early debt extinguishment in fiscal 2021.
Core EPS
Expected Impact of headwinds on Core EPS guidance
| Twelve Months Ended<br><br> June 30, 2021 | |
|---|---|
| Diluted Net Earnings Per Share | $5.50 |
| Early Debt Extinguishment | 0.16 |
| Core EPS | $5.66 |
| Expected Impact of Commodities/Freight/FX headwind on FY2022 EPS | $1.26 |
| Percentage of prior year Diluted Net Earnings Per Share | 23% |
| Percentage of prior year Core EPS | 22% |
- Core gross margin:
| Three Months Ended<br><br> March 31 | ||
|---|---|---|
| 2022 | 2021 | |
| Gross Margin | 46.7% | 50.7% |
| Basis point change vs. prior year gross margin | (400) | |
| Adjustments* | - | - |
| Core Gross Margin | 46.7% | 50.7% |
| Basis point change vs. prior year Core gross margin | (400) | |
| Currency Impact to Margin | 0.2% | |
| Currency-Neutral Core Gross Margin | 46.9% | |
| Basis point change vs prior year Core gross margin | (380) |
*For the three months ended March 31, 2022 compared with the three months ended March 31, 2021, there are no adjustments to or reconciling items for gross margin.
- Core operating profit margin:
| Three Months Ended<br><br> March 31 | ||
|---|---|---|
| 2022 | 2021 | |
| Operating Profit Margin | 20.8% | 20.9% |
| Basis point change vs. prior year operating profit margin | (10) | |
| Adjustments* | - | - |
| Core Operating Profit Margin | 20.8% | 20.9% |
| Basis point change vs. prior year Core operating profit margin | (10) | |
| Currency Impact Margin | 0.2% | |
| Rounding | 0.1% | |
| Currency-Neutral Core Operating Profit Margin | 21.1% | |
| Basis point change vs. prior year operating profit margin | 20 |
*For the three months ended March 31, 2022 compared with the three months ended March 31, 2022, there are no adjustments to or reconciling items for operating profit margin.
- Free cash flow productivity (dollar amounts in millions):
| Three Months Ended March 31, 2022 | ||||
|---|---|---|---|---|
| Operating Cash Flow | Capital Spending | Free Cash Flow | Net Earnings | Free Cash Flow Productivity |
| $3,246 | $(747) | $2,499 | $3,367 | 74% |